Scott Braunstein is the founder of Marinus Pharmaceuticals. Based in RADNOR, Pa., United States.
Scott Braunstein, M.D. is the CEO and Chairman of the Board at Marinus Pharmaceuticals, a pharmaceutical company focused on developing innovative therapeutics for seizure disorders. Under his leadership, the company has seen significant transformation, including the successful U.S. approval and early commercial launch of ZTALMY® (ganaxolone) for CDKL5 Deficiency Disorder.
Full founder directory · Investor directory · Company funding database · Fundraising library